Abstract
No public abstract is available from the verified source records.
Swati Ghosh, Michael W. Devereaux, David J. Orlicky, Karim C. El Kasmi, Ronald J. Sokol
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management
10.1007/s12072-020-10048-8 · 2020
New insights into intestinal failure-associated liver disease in children
10.1002/hep.31152 · 2020
Neonatal cholestasis: updates on diagnostics, therapeutics, and prevention
10.1542/neo.22-12-e819 · 2021
Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children
10.3945/ajcn.116.137083 · 2016
Prevention of parenteral nutrition-associated cholestasis using reduced dose soybean lipid emulsion: a multicenter randomized trial
10.1016/j.jpedsurg.2024.03.030 · 2024
Understanding the dynamics of biochemical liver markers in preterm infants with parenteral nutrition-associated cholestasis may prevent unnecessary invasive examinations
10.1111/apa.17427 · 2025
LRH-1 agonist DLPC through STAT6 promotes macrophage polarization and prevents parenteral nutrition-associated cholestasis in mice
10.1097/hep.0000000000000690 · 2024
NF-kappaB regulation of LRH-1 and ABCG5/8 potentiates phytosterol role in the pathogenesis of parenteral nutrition-associated cholestasis
10.1002/hep.32071 · 2021
Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha
10.1182/blood-2003-07-2427 · 2004
LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner
10.1089/ars.2007.1825 · 2008
Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice
10.1124/jpet.111.189340 · 2012
The role of hypoxic microenvironment in autoimmune diseases
10.3389/fimmu.2024.1435306 · 2024
Hypoxia-inducible factors as molecular targets for liver diseases
10.1007/s00109-016-1408-1 · 2016
The role of HIF in immunity and inflammation
10.1016/j.cmet.2020.08.002 · 2020
Master and commander: epigenetic regulation of macrophages
10.1038/cr.2016.5 · 2016
Polycomb repressive 2 complex-molecular mechanisms of function
10.1002/pro.3647 · 2019
Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes
10.1038/ng.3385 · 2015
EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD
10.3390/ijms141224154 · 2013
FXR, a multipurpose nuclear receptor
10.1016/j.tibs.2006.08.002 · 2006
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
10.1016/s1097-2765(00)00051-4 · 2000
Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice
10.1002/hep.32101 · 2022
Stat3 role in the protective effect of FXR agonist in parenteral nutrition-associated cholestasis
10.1097/hc9.0000000000000056 · 2023
Selective agonism of liver and gut FXR prevents cholestasis and intestinal atrophy in parenterally fed neonatal pigs
10.1016/j.jlr.2025.100919 · 2025
Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression
10.1038/s41419-022-04745-5 · 2022
Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway
10.1111/j.1742-4658.2009.06867.x · 2009
Phosphorylation of EZH2 by AMPK suppresses PRC2 methyltransferase activity and oncogenic function
10.1016/j.molcel.2017.12.024 · 2018
Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury
10.1002/hep.25500 · 2012
Pharmacologic inhibition of HNF4alpha prevents parenteral nutrition associated cholestasis in mice
10.1038/s41598-023-33994-3 · 2023
Hypoxia studies with pimonidazole in vivo
10.21769/bioprotoc.1254 · 2014
Liver inflammation relates to decreased canalicular bile transporter expression in pediatric onset intestinal failure
10.1097/sla.0000000000002187 · 2018
Macrophage-derived IL-1beta/NF-kappaB signaling mediates parenteral nutrition-associated cholestasis
10.1038/s41467-018-03764-1 · 2018
Myeloid hypoxia-inducible factor HIF1A provides cardio-protection during ischemia and reperfusion via induction of netrin-1
10.3389/fcvm.2022.970415 · 2022
HIF1alpha-induced glycolysis metabolism is essential to the activation of inflammatory macrophages
10.1155/2017/9029327 · 2017
Primary cilia, hypoxia, and liver dysfunction: a new perspective on biliary atresia
10.3390/cells14080596 · 2025
The role of the histone methyltransferase EZH2 in liver inflammation and fibrosis in STAM NASH mice
2020
Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors
10.1038/nri1685 · 2005
p38-mediated phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis
10.1038/s41467-018-05078-8 · 2018
Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3
10.1126/science.1118947 · 2005
Beyond expression: role of phosphorylated residues of EZH2 in lineage plasticity in prostate cancer
10.1210/endocr/bqad023 · 2023
Bile acid nuclear receptor FXR and digestive system diseases
10.1016/j.apsb.2015.01.004 · 2015
Long noncoding RNA H19: functions and mechanisms in regulating programmed cell death in cancer
10.1038/s41420-024-01832-8 · doi-reference
Long non-coding RNA H19 promotes the proliferation, migration and invasion while inhibits apoptosis of hypertrophic scarring fibroblasts by targeting miR-3187-3p/GAB1 axis
10.1016/j.burns.2020.07.023 · doi-reference
PI3K signaling-regulated metabolic reprogramming: from mechanism to application
10.1016/j.bbcan.2023.188952 · doi-reference
Luoshi Neiyi prescription inhibits estradiol synthesis and inflammation in endometriosis through the HIF1A/EZH2/SF-1 pathway
10.1016/j.jep.2024.118659 · doi-reference
STAT6 upregulation promotes M2 macrophage polarization to suppress atherosclerosis
10.12659/msmbr.904014 · doi-reference
Hypoxia-dependent regulation of inflammatory pathways in immune cells
10.1172/jci84433 · doi-reference
HIF transcription factors, inflammation, and immunity
10.1016/j.immuni.2014.09.008 · doi-reference
LncRNA H19 inhibits ER stress induced apoptosis and improves diabetic cardiomyopathy by regulating PI3K/AKT/mTOR axis
10.18632/aging.204256 · doi-reference
A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis
10.7554/elife.86168 · doi-reference
EZH2 methyltransferase and H3K27 methylation in breast cancer
10.7150/ijbs.8.59 · doi-reference
EZH2, HIF-1, and their inhibitors: an overview on pediatric cancers
10.3389/fped.2018.00328 · doi-reference
Bile acid nuclear receptor FXR and digestive system diseases
10.1016/j.apsb.2015.01.004 · doi-reference
Beyond expression: role of phosphorylated residues of EZH2 in lineage plasticity in prostate cancer
10.1210/endocr/bqad023 · doi-reference
Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3
10.1126/science.1118947 · doi-reference
p38-mediated phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis
10.1038/s41467-018-05078-8 · doi-reference
Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors
10.1038/nri1685 · doi-reference
Primary cilia, hypoxia, and liver dysfunction: a new perspective on biliary atresia
10.3390/cells14080596 · doi-reference
HIF1alpha-induced glycolysis metabolism is essential to the activation of inflammatory macrophages
10.1155/2017/9029327 · doi-reference
Myeloid hypoxia-inducible factor HIF1A provides cardio-protection during ischemia and reperfusion via induction of netrin-1
10.3389/fcvm.2022.970415 · doi-reference
Macrophage-derived IL-1beta/NF-kappaB signaling mediates parenteral nutrition-associated cholestasis
10.1038/s41467-018-03764-1 · doi-reference
Liver inflammation relates to decreased canalicular bile transporter expression in pediatric onset intestinal failure
10.1097/sla.0000000000002187 · doi-reference
Hypoxia studies with pimonidazole in vivo
10.21769/bioprotoc.1254 · doi-reference
Pharmacologic inhibition of HNF4alpha prevents parenteral nutrition associated cholestasis in mice
10.1038/s41598-023-33994-3 · doi-reference
Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury
10.1002/hep.25500 · doi-reference
Phosphorylation of EZH2 by AMPK suppresses PRC2 methyltransferase activity and oncogenic function
10.1016/j.molcel.2017.12.024 · doi-reference
Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway
10.1111/j.1742-4658.2009.06867.x · doi-reference
Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression
10.1038/s41419-022-04745-5 · doi-reference
Selective agonism of liver and gut FXR prevents cholestasis and intestinal atrophy in parenterally fed neonatal pigs
10.1016/j.jlr.2025.100919 · doi-reference
Stat3 role in the protective effect of FXR agonist in parenteral nutrition-associated cholestasis
10.1097/hc9.0000000000000056 · doi-reference
Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice
10.1002/hep.32101 · doi-reference
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
10.1016/s1097-2765(00)00051-4 · doi-reference
FXR, a multipurpose nuclear receptor
10.1016/j.tibs.2006.08.002 · doi-reference
EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD
10.3390/ijms141224154 · doi-reference
Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes
10.1038/ng.3385 · doi-reference
Polycomb repressive 2 complex-molecular mechanisms of function
10.1002/pro.3647 · doi-reference
Master and commander: epigenetic regulation of macrophages
10.1038/cr.2016.5 · doi-reference
The role of HIF in immunity and inflammation
10.1016/j.cmet.2020.08.002 · doi-reference
Hypoxia-inducible factors as molecular targets for liver diseases
10.1007/s00109-016-1408-1 · doi-reference
The role of hypoxic microenvironment in autoimmune diseases
10.3389/fimmu.2024.1435306 · doi-reference
Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice
10.1124/jpet.111.189340 · doi-reference